Evotec AG Awarded Multi-Year Contract To Manage Evotec AG Chemical Biology Consortium Screening Libraries Center

HAMBURG, Germany--(BUSINESS WIRE)--Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced it has entered into a multi-year compound management agreement with the U.S. National Cancer Institute ("NCI"), Department of Health and Human Services. Under the terms of the agreement, Evotec will provide compound management services to the NCI Chemical Biology Consortium ("CBC") for a period of five years with a total estimated value of up to EUR 4.5 m ($ 4.9 m).

Help employers find you! Check out all the jobs and post your resume.